CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...